This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignee: Advanced Research & Technology Institute. Active years: 2000-2001.
Company Filing History:
Years Active: 2000-2001
Title: The Innovations of Robert Hromas
Introduction
Robert Hromas is a notable inventor based in Indianapolis, IN (US). He has made significant contributions to the field of biomedical research, particularly in the study of chemokines and their roles in viral infections and diseases. With a total of 2 patents, Hromas has demonstrated his expertise and commitment to advancing medical science.
Latest Patents
Hromas's latest patents include groundbreaking work on the functional characterization of C-C chemokine-like molecules encoded by molluscum contagiosum virus types 1 and 2. In this patent, he and his team cloned and expressed the chemokine-like genes from MCV type 1 and MCV type 2 to explore their potential roles in the viral life cycle. This research revealed the first viral chemokines that can antagonize the chemotactic activity of human chemokines and inhibit human hematopoietic progenitor cells. Additionally, he has developed methods and compositions for exploiting these proteins.
Another significant patent focuses on the treatment of myeloproliferative disease with exodus chemokine. This invention provides purified and isolated chemokine proteins, fragments, and polypeptide analogs, along with antibodies and methods for their recombinant production. These products hold promise for therapeutic applications in treating myeloproliferative diseases and for use in diagnostic and medical imaging applications.
Career Highlights
Hromas is affiliated with the Advanced Research & Technology Institute, where he continues to push the boundaries of research in his field. His work has not only contributed to scientific knowledge but also has the potential to lead to new therapeutic strategies for various diseases.
Collaborations
Throughout his career, Hromas has collaborated with esteemed colleagues, including Hal E Broxmeyer and Michell D Krathwohl. These partnerships have enriched his research and expanded the impact of his innovations.
Conclusion
Robert Hromas is a distinguished inventor whose work in the field of chemokines has the potential to transform therapeutic approaches to viral infections and diseases. His contributions are invaluable to the scientific community and hold promise for future advancements in medical science.